Trending stocks today
Khiron Life Sciences (KHRN-X)
CVE:KHRN
0.04
Financials
Technical Analysis
Related posts
Most Anticipated Earnings: UNC-T, DAN-X and more Canadian Companies Reporting Earnings this Week (Nov 27-Dec 01)
N/A
No
They are focused on the medical market in Columbia and more generally in Latin America. They are positioned to be one of the first Columbia-based companies to have product in the domestic market. Their CEO used to manage infrastructure projects for SNC. The other co-founder launched Advil into the country. Another executive has years of experience in the US Drug Enforcement Agency. This is a knowledgeable management team. They plan to replicate their model of doctor engagement throughout South America and Mexico.
- «
- ‹
- 1
- ›
- »
Khiron Life Sciences(KHRN-X) Rating
Ranking : 1 out of 5
Bullish - Buy Signals / Votes : 0
Neutral - Hold Signals / Votes : 0
Bearish - Sell Signals / Votes : 0
Total Signals / Votes : 0
Khiron Life Sciences(KHRN-X) Frequently Asked Questions
What is Khiron Life Sciences stock symbol?
Khiron Life Sciences is a Canadian stock, trading under the symbol KHRN-X on the TSX Venture Exchange (KHRN-CV). It is usually referred to as TSXV:KHRN or KHRN-X
Is Khiron Life Sciences a buy or a sell?
In the last year, there was no coverage of Khiron Life Sciences published on Stockchase.
Is Khiron Life Sciences a good investment or a top pick?
Khiron Life Sciences was recommended as a Top Pick by on . Read the latest stock experts ratings for Khiron Life Sciences.
Why is Khiron Life Sciences stock dropping?
Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.
Is Khiron Life Sciences worth watching?
0 stock analysts on Stockchase covered Khiron Life Sciences In the last year. It is a trending stock that is worth watching.
What is Khiron Life Sciences stock price?
On 2023-05-05, Khiron Life Sciences (KHRN-X) stock closed at a price of $0.04.
